RPA's Greg Fox wins $2.48m in grants to tackle antibiotic use in Vietnam.
An RPA respiratory physician is part of a team awarded $2.48 million by the Department of Foreign Affairs to lead a project on antibiotic use in Vietnam.
Associate Professor Greg Fox has been travelling to Vietnam, in Southeast Asia, several times a year for about a decade, focusing mostly on the prevention and treatment of tuberculosis.
His new three-year project is aimed at preventing antimicrobial resistance.
Drug resistant tuberculosis and respiratory pathogens are increasingly common, and pose a major threat to health in Vietnam and the region.
“Vietnam is a hotspot for the emergence of drug resistant infections, typifying the regional challenges facing health systems in combating antimicrobial resistance,” Associate Professor Fox said.
“While good progress has been made in strengthening surveillance of drug resistance, very little has been done to reduce the drivers in local communities – where most health care interactions occur.
“Excessive and inappropriate use of antibiotics remain a major challenge, but antimicrobial drug resistance can spread to other countries so it is vital for Australia to help improve the way they are used in our region.”
Associate Professor Fox will lead a team from the University of Sydney, University of NSW, the George Institute for Global Health, the National Institute of Hygiene and Epidemiology and the National Lung Hospital, Hanoi, Vietnam, and the Australian National University.
The three-year project will execute a program of research to develop and assess the effectiveness of a package of interventions to guide the Vietnamese government in combating the drivers of antimicrobial resistance.
The project will be done in 36 Districts in population of over five million people.
At the Sydney Research Awards in June 2018, Associate Professor Fox was awarded the Research Excellence Award for his commitment to using research to improve health care among disadvantaged populations.